enVVeno Medical Corporation
NVNO
$10.53
$0.232.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.62M | 11.40M | 12.13M | 11.52M | 11.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.60M | 22.95M | 23.95M | 23.28M | 23.83M |
| Operating Income | -20.60M | -22.95M | -23.95M | -23.28M | -23.83M |
| Income Before Tax | -19.47M | -21.97M | -23.07M | -21.33M | -21.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.47 | -21.97 | -23.07 | -21.33 | -21.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.47M | -21.97M | -23.07M | -21.33M | -21.82M |
| EBIT | -20.60M | -22.95M | -23.95M | -23.28M | -23.83M |
| EBITDA | -20.46M | -22.81M | -23.79M | -23.10M | -23.64M |
| EPS Basic | -33.19 | -37.82 | -42.23 | -41.51 | -44.65 |
| Normalized Basic EPS | -21.19 | -23.89 | -26.74 | -27.69 | -30.02 |
| EPS Diluted | -33.19 | -37.82 | -42.23 | -41.51 | -44.65 |
| Normalized Diluted EPS | -21.19 | -23.89 | -26.74 | -27.69 | -30.02 |
| Average Basic Shares Outstanding | 2.36M | 2.32M | 2.21M | 2.08M | 1.96M |
| Average Diluted Shares Outstanding | 2.36M | 2.32M | 2.21M | 2.08M | 1.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |